{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:14:12Z","timestamp":1793459652438,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>C\u2013C chemokine receptor 5 (CCR5) is a co-receptor of HIV. Epidemiological findings suggest that the functional loss of CCR5 is correlated with a lower incidence of bone-destructive diseases as well as of HIV transmission. However, it is not clear whether CCR5 is involved in regulation of the function of bone cells, in addition to that of immune cells. Here we show that blockade of CCR5 using specific antibodies impairs human osteoclast function in vitro. <jats:italic>Ccr5<\/jats:italic>-deficient (<jats:italic>Ccr5<\/jats:italic><jats:sup>\n                           <jats:italic>\u2212<\/jats:italic>\/<jats:italic>\u2212<\/jats:italic>\n                        <\/jats:sup>) mice presented with dysfunctional osteoclasts and were resistant to osteoporosis induced by receptor activator of nuclear factor kappa-B ligand (RANKL), which triggers osteoporosis independently of inflammatory and immunomodulatory pathways. Furthermore, <jats:italic>Ccr5<\/jats:italic> deficiency impairs the cellular locomotion and bone-resorption activity of osteoclasts, which is associated with the disarrangement of podosomes and adhesion complex molecules including Pyk2. Overall, the data provides evidence that CCR5 has an essential role in bone-destructive conditions\u00a0through the functional regulation of osteoclasts.<\/jats:p>","DOI":"10.1038\/s41467-017-02368-5","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T15:54:04Z","timestamp":1513266844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The HIV co-receptor CCR5 regulates osteoclast function"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4578-2168","authenticated-orcid":false,"given":"Ji-Won","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Saitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ueha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6119-0034","authenticated-orcid":false,"given":"Yuuki","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1431-0689","authenticated-orcid":false,"given":"Tadahiro","family":"Iimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,20]]},"reference":[{"key":"2368_CR1","first-page":"145","volume":"52","author":"PM Murphy","year":"2000","unstructured":"Murphy, P. M. et al. International union of pharmacology. XXII. Nomencl. Chemokine Recept. Pharmacol. Rev. \n                           52, 145\u2013176 (2000).","journal-title":"Nomencl. Chemokine Recept. Pharmacol. Rev."},{"key":"2368_CR2","first-page":"130","volume":"8","author":"A Repik","year":"2007","unstructured":"Repik, A., Richards, K. H. & Clapham, P. R. The promise of CCR5 antagonists as new therapies for HIV-1. Curr. Opin. Investig. Drugs \n                           8, 130\u2013139 (2007).","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"2368_CR3","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","volume":"20","author":"TT Brown","year":"2006","unstructured":"Brown, T. T. & Qaqish, R. B. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS \n                           20, 2165\u20132174 (2006).","journal-title":"AIDS"},{"key":"2368_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00126334-200307010-00001","volume":"33","author":"J Thomas","year":"2003","unstructured":"Thomas, J. & Doherty, S. M. HIV infection\u2014a risk factor for osteoporosis. J. Acquir. Immune Defic. Syndr. \n                           33, 281\u2013291 (2003).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"2368_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1345\/aph.1K465","volume":"42","author":"PG Clay","year":"2008","unstructured":"Clay, P. G., Voss, L. E., Williams, C. & Daume, E. C. Valid treatment options for osteoporosis and osteopenia in HIV-infected persons. Ann. Pharmacother. \n                           42, 670\u2013679 (2008).","journal-title":"Ann. Pharmacother."},{"key":"2368_CR6","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1097\/QAD.0b013e328340a28d","volume":"24","author":"A Bonjoch","year":"2010","unstructured":"Bonjoch, A. et al. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS \n                           24, 2827\u20132833 (2010).","journal-title":"AIDS"},{"key":"2368_CR7","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1097\/QAD.0b013e32833dbc31","volume":"24","author":"A Sharma","year":"2010","unstructured":"Sharma, A., Flom, P. L., Weedon, J. & Klein, R. S. Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS \n                           24, 2337\u20132345 (2010).","journal-title":"AIDS"},{"key":"2368_CR8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/cid\/cit538","volume":"57","author":"PM Grant","year":"2013","unstructured":"Grant, P. M. et al. Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Clin. Infect. Dis. \n                           57, 1483\u20131488 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"2368_CR9","doi-asserted-by":"publisher","first-page":"e11416","DOI":"10.1371\/journal.pone.0011416","volume":"5","author":"PM Grant","year":"2010","unstructured":"Grant, P. M. et al. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS ONE \n                           5, e11416 (2010).","journal-title":"PLoS ONE"},{"key":"2368_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1468-1293.2010.00864.x","volume":"12","author":"AB Hansen","year":"2011","unstructured":"Hansen, A. B., Obel, N., Nielsen, H., Pedersen, C. & Gerstoft, J. Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial. HIV Med. \n                           12, 157\u2013165 (2011).","journal-title":"HIV Med."},{"key":"2368_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9282","volume":"6","author":"I Ofotokun","year":"2015","unstructured":"Ofotokun, I. et al. Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss. Nat. Commun. \n                           6, 8282 (2015).","journal-title":"Nat. Commun."},{"key":"2368_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/MED.0b013e32833f48d6","volume":"17","author":"I Ofotokun","year":"2010","unstructured":"Ofotokun, I. & Weitzmann, M. N. HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture. Curr. Opin. Endocrinol. Diabetes Obes. \n                           17, 523\u2013529 (2010).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"2368_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/sj.gene.6364317","volume":"7","author":"S Prahalad","year":"2006","unstructured":"Prahalad, S. et al. Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis. Genes Immun. \n                           7, 468\u2013475 (2006).","journal-title":"Genes Immun."},{"key":"2368_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/ard.2004.023333","volume":"64","author":"V Pokorny","year":"2005","unstructured":"Pokorny, V. et al. Evidence for negative association of the chemokine receptor CCR5d32 polymorphism with rheumatoid arthritis. Ann. Rheum. Dis. \n                           64, 487\u2013490 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"2368_CR15","first-page":"1462","volume":"25","author":"P Garred","year":"1998","unstructured":"Garred, P. et al. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J. Rheumatol. \n                           25, 1462\u20131465 (1998).","journal-title":"J. Rheumatol."},{"key":"2368_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/1529-0131(199905)42:5<989::AID-ANR18>3.0.CO;2-U","volume":"42","author":"JJ Gomez-Reino","year":"1999","unstructured":"Gomez-Reino, J. J. et al. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum. \n                           42, 989\u2013992 (1999).","journal-title":"Arthritis Rheum."},{"key":"2368_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/sj.gene.6363673","volume":"1","author":"I Zapico","year":"2000","unstructured":"Zapico, I. et al. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun. \n                           1, 288\u2013289 (2000).","journal-title":"Genes Immun."},{"key":"2368_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/03009740701393999","volume":"36","author":"CL Kohem","year":"2007","unstructured":"Kohem, C. L. et al. The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients. Scand. J. Rheumatol. \n                           36, 359\u2013364 (2007).","journal-title":"Scand. J. Rheumatol."},{"key":"2368_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-8-33","volume":"8","author":"E Lindner","year":"2007","unstructured":"Lindner, E. et al. Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis. BMC Med. Genet. \n                           8, 33 (2007).","journal-title":"BMC Med. Genet."},{"key":"2368_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/ar3775","volume":"14","author":"T Takeuchi","year":"2012","unstructured":"Takeuchi, T. & Kameda, H. What is the future of CCR5 antagonists in rheumatoid arthritis? Arthritis Res. Ther. \n                           14, 114 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"2368_CR21","doi-asserted-by":"publisher","first-page":"e13188","DOI":"10.1371\/journal.pone.0013188","volume":"5","author":"N Funderburg","year":"2010","unstructured":"Funderburg, N. et al. Effects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patients. PLoS ONE \n                           5, e13188 (2010).","journal-title":"PLoS ONE"},{"key":"2368_CR22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/infdis\/jis376","volume":"206","author":"TJ Wilkin","year":"2012","unstructured":"Wilkin, T. J. et al. A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4(+) T-cell recovery despite sustained virologic suppression: ACTG A5256. J. Infect. Dis. \n                           206, 534\u2013542 (2012).","journal-title":"J. Infect. Dis."},{"key":"2368_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/jac\/dks432","volume":"68","author":"H Arberas","year":"2013","unstructured":"Arberas, H. et al. In vitro effects of the CCR5 inhibitor maraviroc on human T cell function. J. Antimicrob. Chemother. \n                           68, 577\u2013586 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"2368_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/infdis\/jiu180","volume":"210","author":"MM Pozo-Balado","year":"2014","unstructured":"Pozo-Balado, M. M. et al. Maraviroc reduces the regulatory T-cell frequency in antiretroviral-naive HIV-infected subjects. J. Infect. Dis. \n                           210, 890\u2013898 (2014).","journal-title":"J. Infect. Dis."},{"key":"2368_CR25","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1182\/blood-2012-06-436345","volume":"121","author":"PW Hunt","year":"2013","unstructured":"Hunt, P. W. et al. The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. Blood \n                           121, 4635\u20134646 (2013).","journal-title":"Blood"},{"key":"2368_CR26","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/cid\/civ455","volume":"61","author":"BO Taiwo","year":"2015","unstructured":"Taiwo, B. O. et al. Less bone loss with maraviroc-versus tenofovir-containing antiretroviral therapy in the aids clinical trials group A5303 study. Clin. Infect. Dis. \n                           61, 1179\u20131188 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"2368_CR27","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1210\/en.2005-0065","volume":"146","author":"S Yano","year":"2005","unstructured":"Yano, S. et al. Functional expression of beta-chemokine receptors in osteoblasts: role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts. Endocrinology \n                           146, 2324\u20132335 (2005).","journal-title":"Endocrinology"},{"key":"2368_CR28","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1182\/blood.V97.11.3349","volume":"97","author":"JH Han","year":"2001","unstructured":"Han, J. H. et al. Macrophage inflammatory protein-1-alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood \n                           97, 3349\u20133353 (2001).","journal-title":"Blood"},{"key":"2368_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.exphem.2004.11.015","volume":"33","author":"Y Oba","year":"2005","unstructured":"Oba, Y. et al. MIP-1-alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Exp. Hematol. \n                           33, 272\u2013278 (2005).","journal-title":"Exp. Hematol."},{"key":"2368_CR30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1177\/0022034509346230","volume":"88","author":"I Andrade Jr.","year":"2009","unstructured":"Andrade, I. Jr. et al. CCR5 down-regulates osteoclast function in orthodontic tooth movement. J. Dent. Res \n                           88, 1037\u20131041 (2009).","journal-title":"J. Dent. Res"},{"key":"2368_CR31","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1002\/jbmr.1937","volume":"28","author":"K Wintges","year":"2013","unstructured":"Wintges, K. et al. Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine (C\u2013C motif) ligand 5 (Ccl5). J. Bone Miner. Res. \n                           28, 2070\u20132080 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"2368_CR32","doi-asserted-by":"publisher","first-page":"C874","DOI":"10.1152\/ajpcell.00294.2003","volume":"287","author":"M Amoui","year":"2004","unstructured":"Amoui, M., Suhr, S. M., Baylink, D. J. & Lau, K. H. An osteoclastic protein-tyrosine phosphatase may play a role in differentiation and activity of human monocytic U-937 cell-derived, osteoclast-like cells. Am. J. Physiol. Cell Physiol. \n                           287, C874\u2013C884 (2004).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2368_CR33","doi-asserted-by":"publisher","first-page":"7484","DOI":"10.1074\/jbc.M008368200","volume":"276","author":"LT Duong","year":"2001","unstructured":"Duong, L. T. et al. Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2. J. Biol. Chem. \n                           276, 7484\u20137492 (2001).","journal-title":"J. Biol. Chem."},{"key":"2368_CR34","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1128\/MCB.00851-08","volume":"29","author":"A Bruzzaniti","year":"2009","unstructured":"Bruzzaniti, A. et al. Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts. Mol. Cell Biol. \n                           29, 3644\u20133656 (2009).","journal-title":"Mol. Cell Biol."},{"key":"2368_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1083\/jcb.200701148","volume":"178","author":"H Gil-Henn","year":"2007","unstructured":"Gil-Henn, H. et al. Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-\/-) mice. J. Cell Biol. \n                           178, 1053\u20131064 (2007).","journal-title":"J. Cell Biol."},{"key":"2368_CR36","doi-asserted-by":"publisher","first-page":"11502","DOI":"10.1074\/jbc.M206579200","volume":"278","author":"PT Lakkakorpi","year":"2003","unstructured":"Lakkakorpi, P. T., Bett, A. J., Lipfert, L., Rodan, G. A. & Duong, L. T. PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption. J. Biol. Chem. \n                           278, 11502\u201311512 (2003).","journal-title":"J. Biol. Chem."},{"key":"2368_CR37","doi-asserted-by":"publisher","first-page":"17660","DOI":"10.1074\/jbc.M311032200","volume":"279","author":"T Miyazaki","year":"2004","unstructured":"Miyazaki, T. et al. Src kinase activity is essential for osteoclast function. J. Biol. Chem. \n                           279, 17660\u201317666 (2004).","journal-title":"J. Biol. Chem."},{"key":"2368_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1083\/jcb.200207036","volume":"160","author":"Q Wang","year":"2003","unstructured":"Wang, Q. et al. Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin. J. Cell Biol. \n                           160, 565\u2013575 (2003).","journal-title":"J. Cell Biol."},{"key":"2368_CR39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S8756-3282(02)00834-7","volume":"31","author":"Z Zhang","year":"2002","unstructured":"Zhang, Z., Neff, L., Bothwell, A. L., Baron, R. & Horne, W. C. Calcitonin induces dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in osteoclasts. Bone \n                           31, 359\u2013365 (2002).","journal-title":"Bone"},{"key":"2368_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1172\/JCI15797","volume":"114","author":"MW Wang","year":"2004","unstructured":"Wang, M. W. et al. The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling. J. Clin. Invest. \n                           114, 206\u2013213 (2004).","journal-title":"J. Clin. Invest."},{"key":"2368_CR41","doi-asserted-by":"publisher","first-page":"28826","DOI":"10.1074\/jbc.M109.099424","volume":"285","author":"A Hoshino","year":"2010","unstructured":"Hoshino, A. et al. Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts. J. Biol. Chem. \n                           285, 28826\u201328837 (2010).","journal-title":"J. Biol. Chem."},{"key":"2368_CR42","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.bbrc.2005.04.015","volume":"331","author":"P Di Marzio","year":"2005","unstructured":"Di Marzio, P. et al. Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages. Biochem. Biophys. Res. Commun. \n                           331, 909\u2013916 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2368_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1749-6632.2011.06283.x","volume":"1240","author":"SL Teitelbaum","year":"2011","unstructured":"Teitelbaum, S. L. The osteoclast and its unique cytoskeleton. Ann. N. Y. Acad. Sci. \n                           1240, 14\u201317 (2011).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2368_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10585-006-9038-6","volume":"23","author":"E Menu","year":"2006","unstructured":"Menu, E. et al. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model. Clin. Exp. Metastasis \n                           23, 291\u2013300 (2006).","journal-title":"Clin. Exp. Metastasis"},{"key":"2368_CR45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/ard.2005.037176","volume":"65","author":"JJ Haringman","year":"2006","unstructured":"Haringman, J. J., Smeets, T. J., Reinders-Blankert, P. & Tak, P. P. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann. Rheum. Dis. \n                           65, 294\u2013300 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"2368_CR46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V96.2.671","volume":"96","author":"SJ Choi","year":"2000","unstructured":"Choi, S. J. et al. Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood \n                           96, 671\u2013675 (2000).","journal-title":"Blood"},{"key":"2368_CR47","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1091\/mbc.E04-12-1117","volume":"16","author":"A Bruzzaniti","year":"2005","unstructured":"Bruzzaniti, A. et al. Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity. Mol. Biol. Cell \n                           16, 3301\u20133313 (2005).","journal-title":"Mol. Biol. Cell"},{"key":"2368_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.0105-2896.2005.00335.x","volume":"208","author":"WC Horne","year":"2005","unstructured":"Horne, W. C., Sanjay, A., Bruzzaniti, A. & Baron, R. The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function. Immunol. Rev. \n                           208, 106\u2013125 (2005).","journal-title":"Immunol. Rev."},{"key":"2368_CR49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejcb.2006.01.008","volume":"85","author":"MA Chellaiah","year":"2006","unstructured":"Chellaiah, M. A. Regulation of podosomes by integrin alphavbeta3 and Rho GTPase-facilitated phosphoinositide signaling. Eur. J. Cell Biol. \n                           85, 311\u2013317 (2006).","journal-title":"Eur. J. Cell Biol."},{"key":"2368_CR50","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1242\/jcs.086280","volume":"124","author":"M Croke","year":"2011","unstructured":"Croke, M. et al. Rac deletion in osteoclasts causes severe osteopetrosis. J. Cell. Sci. \n                           124, 3811\u20133821 (2011).","journal-title":"J. Cell. Sci."},{"key":"2368_CR51","doi-asserted-by":"publisher","first-page":"32930","DOI":"10.1074\/jbc.M500154200","volume":"280","author":"MA Chellaiah","year":"2005","unstructured":"Chellaiah, M. A. Regulation of actin ring formation by rho GTPases in osteoclasts. J. Biol. Chem. \n                           280, 32930\u201332943 (2005).","journal-title":"J. Biol. Chem."},{"key":"2368_CR52","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1242\/jcs.113910","volume":"126","author":"A Hoshino","year":"2013","unstructured":"Hoshino, A. et al. Roles of chemokine receptor CX3CR1 in maintaining murine bone homeostasis through the regulation of both osteoblasts and osteoclasts. J. Cell. Sci. \n                           126, 1032\u20131045 (2013).","journal-title":"J. Cell. Sci."},{"key":"2368_CR53","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nm.1945","volume":"15","author":"NB Binder","year":"2009","unstructured":"Binder, N. B. et al. Estrogen-dependent and C\u2013C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat. Med. \n                           15, 417\u2013424 (2009).","journal-title":"Nat. Med."},{"key":"2368_CR54","doi-asserted-by":"publisher","first-page":"11427","DOI":"10.1074\/jbc.M010750200","volume":"276","author":"M Wong","year":"2001","unstructured":"Wong, M. et al. Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells. J. Biol. Chem. \n                           276, 11427\u201311431 (2001).","journal-title":"J. Biol. Chem."},{"key":"2368_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1044-5323(02)00123-9","volume":"15","author":"MM Wong","year":"2003","unstructured":"Wong, M. M. & Fish, E. N. Chemokines: attractive mediators of the immune response. Semin. Immunol. \n                           15, 5\u201314 (2003).","journal-title":"Semin. Immunol."},{"key":"2368_CR56","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bcp.2008.11.014","volume":"77","author":"CY Huang","year":"2009","unstructured":"Huang, C. Y. et al. CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways. Biochem. Pharmacol. \n                           77, 794\u2013803 (2009).","journal-title":"Biochem. Pharmacol."},{"key":"2368_CR57","doi-asserted-by":"publisher","first-page":"e35101","DOI":"10.1371\/journal.pone.0035101","volume":"7","author":"SW Wang","year":"2012","unstructured":"Wang, S. W. et al. CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma. PLoS ONE \n                           7, e35101 (2012).","journal-title":"PLoS ONE"},{"key":"2368_CR58","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1128\/MCB.05980-11","volume":"31","author":"W Wei","year":"2011","unstructured":"Wei, W. et al. Biphasic and dosage-dependent regulation of osteoclastogenesis by beta-catenin. Mol. Cell Biol. \n                           31, 4706\u20134719 (2011).","journal-title":"Mol. Cell Biol."},{"key":"2368_CR59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00223-014-9865-4","volume":"95","author":"CS Thudium","year":"2014","unstructured":"Thudium, C. S. et al. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation. Calcif. Tissue Int. \n                           95, 83\u201393 (2014).","journal-title":"Calcif. Tissue Int."},{"key":"2368_CR60","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/0022034513476037","volume":"92","author":"T Matsumoto","year":"2013","unstructured":"Matsumoto, T., Iimura, T., Ogura, K., Moriyama, K. & Yamaguchi, A. The role of osteocytes in bone resorption during orthodontic tooth movement. J. Dent. Res. \n                           92, 340\u2013345 (2013).","journal-title":"J. Dent. Res."},{"key":"2368_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.archoralbio.2014.08.013","volume":"60","author":"Y Nishiyama","year":"2015","unstructured":"Nishiyama, Y. et al. Changes in the spatial distribution of sclerostin in the osteocytic lacuno-canalicular system in alveolar bone due to orthodontic forces, as detected on multimodal confocal fluorescence imaging analyses. Arch. Oral Biol. \n                           60, 45\u201354 (2015).","journal-title":"Arch. Oral Biol."},{"key":"2368_CR62","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ceb.2013.10.003","volume":"27","author":"R Irannejad","year":"2014","unstructured":"Irannejad, R. & von Zastrow, M. GPCR signaling along the endocytic pathway. Curr. Opin. Cell Biol. \n                           27, 109\u2013116 (2014).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2368_CR63","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1161\/CIRCULATIONAHA.114.010757","volume":"130","author":"V Amsellem","year":"2014","unstructured":"Amsellem, V. et al. CCR5 as a treatment target in pulmonary arterial hypertension. Circulation \n                           130, 880\u2013891 (2014).","journal-title":"Circulation"},{"key":"2368_CR64","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1158\/0008-5472.CAN-16-2913","volume":"77","author":"Y Ban","year":"2017","unstructured":"Ban, Y. et al. Targeting autocrine CCL5-CCR5 axis reprograms immunosuppressive myeloid cells and reinvigorates antitumor immunity. Cancer Res. \n                           77, 2857\u20132868 (2017).","journal-title":"Cancer Res."},{"key":"2368_CR65","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ni879","volume":"4","author":"M Murai","year":"2003","unstructured":"Murai, M. et al. Peyer\u2019s patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat. Immunol. \n                           4, 154\u2013160 (2003).","journal-title":"Nat. Immunol."},{"key":"2368_CR66","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1359\/JBMR.050610","volume":"20","author":"M Ito","year":"2005","unstructured":"Ito, M. et al. Multi-detector row CT imaging of vertebral microstructure for evaluation of fracture risk. J. Bone Miner. Res. \n                           20, 1828\u20131836 (2005).","journal-title":"J. Bone Miner. Res."},{"key":"2368_CR67","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt, A. M. et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. \n                           2, 595\u2013610 (1987).","journal-title":"J. Bone Miner. Res."},{"key":"2368_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. \n                           28, 2\u201317 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"2368_CR69","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1093\/bioinformatics\/btr490","volume":"27","author":"EA Howe","year":"2011","unstructured":"Howe, E. A., Sinha, R., Schlauch, D. & Quackenbush, J. RNA-Seq analysis in MeV. Bioinformatics \n                           27, 3209\u20133210 (2011).","journal-title":"Bioinformatics"},{"key":"2368_CR70","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. \n                           4, 44\u201357 (2009).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-02368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-02368-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-02368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T23:42:01Z","timestamp":1671752521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-02368-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,20]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["2368"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-02368-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,20]]},"assertion":[{"value":"1 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2226"}}